Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary Report

Diana Lee, Laura E. Avena, Daniela Montes Berrueta, Matthew Koch, Angela Choi, Judy Oestreicher, William Hillebrand, Honghong Zhou, Rolando Pajon, Andrea Carfi, Darin Edwards, Kai Wu
doi: https://doi.org/10.1101/2022.01.28.21268247

Article Information

doi 
https://doi.org/10.1101/2022.01.28.21268247
History 
  • January 30, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Diana Lee*,
  2. Laura E. Avena*,
  3. Daniela Montes Berrueta*,
  4. Matthew Koch*,
  5. Angela Choi,
  6. Judy Oestreicher,
  7. William Hillebrand,
  8. Honghong Zhou,
  9. Rolando Pajon,
  10. Andrea Carfi,
  11. Darin Edwards† and
  12. Kai Wu#
  1. 1Moderna Inc., 200 Technology Square, Cambridge, Massachusetts, 02139, USA
  1. ↵#Corresponding author:
    Kai Wu, PhD, Moderna, Inc., 200 Technology Square, Cambridge, Massachusetts 02139, USA, Email: Kai.Wu{at}modernatx.com, Phone: 617-417-6780
  2. ↵†Alternative corresponding author:
    Darin Edwards, PhD, Moderna, Inc., 200 Technology Square, Cambridge, Massachusetts 02139, USA, Email: Darin.Edwards{at}modernatx.com, Phone: 617-710-3119

  1. ↵* Contributed equally to this study

Back to top
Posted January 30, 2022.
Download PDF
Data/Code
Email
Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary Report
Diana Lee, Laura E. Avena, Daniela Montes Berrueta, Matthew Koch, Angela Choi, Judy Oestreicher, William Hillebrand, Honghong Zhou, Rolando Pajon, Andrea Carfi, Darin Edwards, Kai Wu
medRxiv 2022.01.28.21268247; doi: https://doi.org/10.1101/2022.01.28.21268247
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area